OVARIAN CANCER and US

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, January 09, 2010

Cancer genetic predisposition: information needs of patients irrespective of risk level.



"Participants were stratified by risk level and included those concerned about an inherited predisposition to breast, ovarian or colorectal cancer."
"Findings indicated that irrespective of a person's actual or perceived level of risk, cancer worry, demographic background or personal motivation; priorities in the type of information required were similar. Greatest emphasis focused on information provision about how risk was assessed. Least important was acquiring an understanding about genes and inheritance patterns. Most participants reported difficulties accessing or finding information."

The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer.



Improving the Quality of Colorectal Cancer Screening: Assessment of Familial Risk.



"Many patients reporting a known familial cancer syndrome or a very strong family history did not have that history indicated on the endoscopist's procedure form, and recommended follow-up intervals were beyond guideline recommendations for 60.4% of the very high-risk group."

(Texas) Cedar Park woman, fearing high cancer risk, chooses hysterectomy, double mastectomy



plus commentaries from oncologists

Avemar - corporate website



This page shows past research with the pdf files being fully accessible. I haven't looked at the research/quality, so have no comment on this one - anyone?

full free access: Risk factors for breast cancer in postmenopausal Caucasian and Chinese-Canadian women



What "best practice" could be in Palliative Care: an analysis of statements on practice and ethics expressed by the main Health Organizations



Current Issue : Menopause



Note: this journal requires a subscription to access the full text of the articles. You can, however, access the abstracts.

The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30.



When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology



abstract: Using More End-of-Life Homecare Services is Associated With Using Fewer Acute Care Services: A Population-Based Cohort Study.



Note: look at the hours

Occult fallopian tube carcinoma detected in routine pelvic washing specimens submitted for staging: another justification for pelvic washing cytology?



Diagn Cytopathol. 2009 Dec;

Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA. jjorns@umich.edu

"Peritoneal washing cytology is important in the staging, prognosis, and treatment schema for women diagnosed with gynecologic malignancies. Additionally, peritoneal washings are often performed before the specific diagnosis or even the distinction between benign or malignant lesion is known. Occasionally, the cytology and surgical pathology specimens, although obtained during the same procedure, will show unexpected and/or discordant findings. Perhaps, the greatest dilemma occurs when atypical cells suggestive of malignancy are identified in peritoneal washing specimens when a corresponding benign or discordantly low grade malignant diagnosis is made in the surgical pathology specimen. We present two such cases in which further investigation proved extremely valuable, not only leading to resolution of initially discrepant cytologic and surgical pathology findings but also in the process leading to second diagnoses of early fallopian tube carcinoma. Increasing evidence appears to be pointing to the fallopian tube as the site of origin of many serous carcinomas previously thought to be of primary pelvic or ovarian origin. These cases further confirm the utility of peritoneal washing cytology as a diagnostic modality when routine gross examination and sampling of the surgical specimens alone would have failed to provide the complete diagnosis."

2010 surgical oncology: Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.



"Experience with lymph node involvement (LNI) in ovarian serous tumors of low malignant potential (OSLMP) is limited, which has led to an uncertainty about the clinical significance of this phenomenon....."

from February 2009: Ovarian - GEICO - ESMO - European Society for Medical Oncology



the actual program itinerary and related abstracts:
http://www.doctaforum.com/aocsymp2009/

Prognostic factors for complete debulking in first- and second-line ovarian cancer.




Lymph node-positive stage IIIC ovarian cancer: a separate entity?




abstract: Consolidation therapy in ovarian cancer: a clinical update.